RT Journal Article
SR Electronic
T1 Artificial Intelligence-Assisted Loop Mediated Isothermal Amplification (ai-LAMP) for Rapid Detection of SARS-CoV-2
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.08.20148999
DO 10.1101/2020.07.08.20148999
A1 Rohaim, Mohammed A
A1 Clayton, Emily
A1 Sahin, Irem
A1 Vilela, Julianne
A1 Khalifa, Manar E
A1 Al-Natour, Mohammad Q
A1 Bayoumi, Mahmoud
A1 Poirier, Aurore
A1 Branavan, Manoharanehru
A1 Tharmakulasingam, Mukunthan
A1 Chaudhry, Nouman S
A1 Sodi, Ravinder
A1 Brown, Amy
A1 Burkhart, Peter
A1 Hacking, Wendy
A1 Botham, Judy
A1 Boyce, Joe
A1 Wilkinson, Hayley
A1 Williams, Craig
A1 Bates, Michelle
A1 La Ragione, Roberto
A1 Balachandran, Wamadeva
A1 Fernando, Anil
A1 Munir, Muhammad
YR 2020
UL http://medrxiv.org/content/early/2020/07/15/2020.07.08.20148999.abstract
AB Until vaccines and effective therapeutics become available, the practical solution to transit safely out of the current coronavirus disease 19 (CoVID-19) lockdown may include the implementation of an effective testing, tracing and tracking system. However, this requires a reliable and clinically validated diagnostic platform for the sensitive and specific identification of SARS-CoV-2. Here, we report on the development of a de novo, high-resolution and comparative genomics guided reverse-transcribed loop-mediated isothermal amplification (LAMP) assay. To further enhance the assay performance and to remove any subjectivity associated with operator interpretation of results, we engineered a novel hand-held smart diagnostic device. The robust diagnostic device was further furnished with automated image acquisition and processing algorithms, and the collated data was processed through artificial intelligence (AI) pipelines to further reduce the assay run time and the subjectivity of the colorimetric LAMP detection. This advanced AI algorithm-implemented LAMP (ai-LAMP) assay, targeting the RNA-dependent RNA polymerase gene, showed high analytical sensitivity and specificity for SARS-CoV-2. A total of ∼200 coronavirus disease (CoVID-19)-suspected NHS patient samples were tested using the platform and it was shown to be reliable, highly specific and significantly more sensitive than the current gold standard qRT-PCR. Therefore, system could provide an efficient and cost-effective platform to detect SARS-CoV-2 in resource-limited laboratories.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors wish to express our sincere appreciation to the BBSRC for allowing us to repurpose the LAMP prototypes produced in the grant BB/R012695/1 to be used for SARS-CoV-2 laboratory testing at The University of Lancaster. We would like to thank the support of BBSRC (BB/M008681/1 and BBS/E/I/00001852) and British Council (172710323 and 332228521) at Division of Biomedical and Life Sciences, Lancaster University, UK. We would also like to thank Brunel University London and the University of Surrey for providing some financial support to rapidly produce these devices.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was conducted in accordance with the University Human ethics guidelines and received a favourable review from the Faculty of Health and Medicine Research Ethics Committee (FHMREC) of Lancaster University - reference number FHMREC19112.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data required has been made available within the manuscript.